N Anthony Coles's Net Worth

$106 Million

Estimate Recalculated Nov 7, 2024 11:34AM EST

Who is N Anthony Coles?

N Anthony Coles has an estimated net worth of $106 Million. This is based on reported shares across multiple companies, which include LABORATORY CORP OF AMERICA HOLDINGS, REGENERON PHARMACEUTICALS, INC., MCKESSON CORP, Cerevel Therapeutics Holdings, Inc., CRISPR Therapeutics AG, Campus Crest Communities, Inc., YUMANITY THERAPEUTICS, INC., VERTEX PHARMACEUTICALS INC / MA, NPS PHARMACEUTICALS INC, and ONYX PHARMACEUTICALS INC.

SEC CIK

N Anthony Coles's CIK is 0001197018

Past Insider Trading and Trends

2023 was N Anthony Coles's most active year for acquiring shares with 18 total transactions. N Anthony Coles's most active month to acquire stocks was the month of December. 2023 was N Anthony Coles's most active year for disposing of shares, totalling 32 transactions. N Anthony Coles's most active month to dispose stocks was the month of August. 2012 saw N Anthony Coles paying a total of $11,145,795.22 for 614,766 shares, this is the most they've acquired in one year. In 2012 N Anthony Coles cashed out on 800,771 shares for a total of $21,372,557.78, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LABORATORY CORP OF AMERICA HOLDINGS (LH) Snapshot price: $223.91

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-7.71%
-216.00
—
—
2.58K
Feb 15
Form 4
+180.00%
1.8K
—
—
2.8K
May 24
Form 4
+233.33%
700
—
—
1K
May 11
Form 4
∞
300
—
—
300
Jan 3
Form 3
—
0
—
—
0
No matching records found

REGENERON PHARMACEUTICALS, INC. (REGN) Snapshot price: $1131.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.73%
135
—
—
1.39K
Jan 2
Form 4
+15.10%
165
—
—
1.26K
Jan 3
Form 4
—
0
$578.17
-$1,565,411.58
1.09K
Scheduled
Dec 28
Form 4
—
0
$476.84
-$1,253,229.17
1.09K
Scheduled
Sep 6
Form 4
+21.18%
191
—
—
1.09K
Jan 3
Form 4
—
0
$512.49
-$3,500,676.85
902
Scheduled
Sep 15
Form 4
—
0
$497.74
-$1,827,180.00
902
Scheduled
Aug 17 - Aug 18
Form 4
—
0
$485.24
-$559,060.00
902
Scheduled
Aug 13
Form 4
+37.92%
248
—
—
902
Jan 4
Form 4
+1.71%
11
$345.47
$3,800.17
654
Nov 13
Form 4
+99.07%
320
—
—
643
Jan 2
Form 4
∞
323
—
—
323
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 27
Form 3
—
0
—
—
0
No matching records found

MCKESSON CORP (MCK) Snapshot price: $504.17

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.45K
$156.77
-$384,559.26
0
Aug 17
Form 4
+89.27%
1.16K
—
—
2.45K
Jul 29
Form 4
∞
1.3K
—
—
1.3K
Jul 31
Form 4
-100.00%
-1.35K
$128.69
-$173,731.50
0
Scheduled
Aug 31
Form 4
∞
1.35K
—
—
1.35K
Jul 25
Form 4
—
0
—
—
0
Jul 26
Form 4
—
0
—
—
0
Jul 27
Form 4
—
0
—
—
0
Jul 29
Form 4
—
0
—
—
0
Jul 30
Form 4
—
0
—
—
0
May 15
Form 3
—
0
—
—
0
No matching records found

Cerevel Therapeutics Holdings, Inc. (CERE) No price found

CEO and Chairperson

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$22.34
-$942,035.00
25.93K
Jul 1
Form 4
+65.80%
10.29K
—
—
25.93K
Jun 5
Form 4
—
0
$22.06
-$1,855,520.00
15.64K
Jun 3
Form 4
—
0
$22.80
-$1,930,125.00
15.64K
May 10
Form 4
—
0
$22.92
-$1,941,640.00
15.64K
Apr 1
Form 4
—
0
$22.26
-$1,875,550.00
15.64K
Mar 4
Form 4
—
0
$22.33
-$1,882,890.00
15.64K
Feb 29
Form 4
+478.33%
12.93K
$41.54
-$104,109.51
15.64K
Feb 6 - Feb 7
Form 4
—
0
$22.87
-$1,936,815.00
2.7K
Jan 2
Form 4
—
0
$14.32
-$493,571.28
2.7K
Nov 14
Form 4
—
0
$14.26
-$584,955.24
2.7K
Nov 7 - Nov 8
Form 4
—
0
$14.42
-$2,183,697.46
2.7K
Nov 2 - Nov 3
Form 4
—
0
$13.79
-$1,028,415.00
2.7K
Sep 7
Form 4
—
0
$16.77
-$1,326,340.00
2.7K
Jul 11
Form 4
—
0
$18.05
-$1,455,070.00
2.7K
Jun 1
Form 4
—
0
$17.49
-$1,398,433.57
2.7K
Scheduled
May 4
Form 4
—
0
$14.28
-$1,078,130.00
2.7K
Apr 11
Form 4
—
0
$15.31
-$1,180,946.80
2.7K
Scheduled
Mar 2 - Mar 3
Form 4
—
0
$18.32
-$1,481,400.61
2.7K
Scheduled
Feb 6 - Feb 7
Form 4
—
0
$16.72
-$1,321,871.30
2.7K
Scheduled
Jan 5
Form 4
—
0
$15.09
-$1,158,300.05
2.7K
Scheduled
Dec 9
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Oct 28
Form 3
—
0
—
—
0
No matching records found

CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
+100.00%
70K
$14.00
$980,000.00
140K
Oct 24
Form 4
—
0
—
—
0
Oct 18
Form 3
—
0
—
—
0
No matching records found